Exane BNP Paribas analyst Xian Siew downgraded Brunswick to Neutral from Outperform with a price target of $82, down from $94. The firm thinks there is investor appetite for early cyclical names if earnings are troughing, but sees risks to 2024 guidance and sees regulations risk in 2025 for Brunswick, the analyst tells investors, adding that consensus “numbers seem too high” for 2024 and 2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BC:
- Brunswick Corporation Schedules First Quarter Earnings Conference Call
- Brunswick Corporation Named one of ‘America’s Most Trustworthy Companies’ by Newsweek for Second Consecutive Year
- Brunswick on DA Davidson ‘Stampede’ list for regulatory risk
- Brunswick price target raised to $115 from $97 at Jefferies
- Brunswick Corporation to Present at Raymond James Conference
